Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Renato Ivo Ferreira Da Silva

    Autor

  • Jorge Manuel Da Silva Junqueira Polónia

    Autor

  • Fernanda Inês De Carvalho Pereira Ribeiro

    Autor

Participantes de fora da FMUP

  • Alves, JM
  • Vieira, C
  • Silva, AM
  • Marques, J
  • Morato, M

Unidades de investigação

Abstract

The close contact between patients and community pharmacists, along with the extensive geographical distribution of pharmacies in Portugal, offer exceptional conditions to detect and report adverse drug reactions (ADR). This study aimed to evaluate the motivation and knowledge of spontaneous reporting of ADR by community pharmacists of Porto, Portugal. Secondly, we aimed to generate real-world evidence on the main factors determining ADR report and at raising potential alternatives to the current reporting procedure in community pharmacy. We performed a descriptive, cross-sectional, observational, anonymous web survey-based study. Between April and July 2021, a web survey was implemented, targeting community pharmacists in the Porto district, Portugal. We validated 217 surveys from pharmacists. Regular notifiers seem to be more familiarised than non-regular notifiers with the Portuguese Pharmacovigilance System (PPS), with the Portal RAM for reporting suspected ADR, and with the update of the concept of ADR. Moreover, regular notifiers seem to be more proactive with their care in questioning patients about ADR and have more self-knowledge to identify suspected ADR. Conversely, non-regular notifiers, seem to be more reluctant to be judged by their ADR reporting activities. Respondents suggested to simplify and optimise the reporting process (31% of the suggestions), or to integrate a reporting platform into the pharmacy's software (27%). This study identified opportunities to promote the ADR reporting process by community pharmacists, namely receiving feedback from the PPS on the reported case and its regulatory implications, implementing training programs in pharmacovigilance, and creating solutions to simplify the reporting process.

Dados da publicação

ISSN/ISSNe:
0094-5145, 1573-3610

Journal of Community Health  Springer Netherlands

Tipo:
Article
Páginas:
295-308
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 1

Citações Recebidas na Scopus: 1

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Adverse drug reaction reporting systems; Health knowledge; Attitudes; Practice; Pharmacist; Community Pharmacist; Pharmacovigilance; Drug monitoring

Financiamento

Proyectos asociados

Post-marketing Surveillance Study of the Effectiveness and Safety of New Oral Antivirals for Outpatients With Mild-moderate COVID-19 (ESOA-19) - NCT05894603

Investigador Principal: Renato Ivo Ferreira da Silva

Estudo Observacional Académico (ESOA-19) . 2022

Impact of EU label changes and regulatory communication on SARS-CoV-2 adenovirus vector vaccines in context of thrombosis with thrombocytopenia syndrome (TTS): risk awareness and adherence.

Investigador Principal: Fernanda Inês de Carvalho Pereira Ribeiro

Estudo Observacional Académco (RiskAwareTTS) . 2022

Comparison of Blood Pressure Variability Between 24H Ambulatory Monitoring and Office Blood Pressure in Diabetics and Non-diabetic Patients a Cross-Sectional Study.

Investigador Principal: Jorge Manuel da Silva Junqueira Polónia

Estudo Clínico Académico . 2021

Hipertensão da bata branca: prognóstico cardiovascular quando definida pela normalidade da pressão arterial noturna.

Investigador Principal: Jorge Manuel da Silva Junqueira Polónia

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação